SomnoMed Limited (ASX:SOM) stated that since the trading update in early June, the company has witnessed the sales trend continue on a positive track to wrap up the year better than its anticipations.
The company revealed that the group revenue for Q4 is reported to be A$8.5 million dwindled by 46% on the same period last year.
Total unaudited group revenues for FY20 are nearly A$57.3 million, only slightly behind the A$58.8 million posted in the previous year.
SomnoMed had a cash balance of A$30 million as of 30 June 2020 and generated A$700,000 operating cash during the quarter.
Which stock gained the most attention in 2019? Find out in our exclusive report on the much talked about lithium stocks which gained the most investor attention amidst the volatile and high drama electric vehicle market.
Read about the shift in the Electric Vehicle market in 2020 and the consequent focus on Lithium in our report.
Get an insight into the lithium prices and the trends. The supply glut kept the lithium prices in check. The escalated bilateral trade dispute between the United States and China significantly impacted the lithium chemical prices.
Understand the performance of mining companies. The lithium mining companies managed to sail through the turbulent white gold market by limiting the production in correspondence with the demand from the offtake partners.